Short answer: yes, and the numbers are hard to ignore. In phase 2 trials, people lost up to 24% of their body weight over 48 weeks. That is more than any other weight loss drug tested so far. But before you get excited, there is a lot worth understanding about how it works, what the side effects look like, and whether it is actually right for you.
Let me walk you through what the research shows. working with a qualified online personal trainer
How Does Retatrutide Work in the Body?
Retatrutide is a triple hormone receptor agonist. That means it activates three receptors at once: GLP-1, GIP, and glucagon. Most people have heard of GLP-1 drugs like semaglutide. Retatrutide does everything semaglutide does, and then adds two more mechanisms on top.
Here is what each one does.
- GLP-1 (glucagon-like peptide-1) slows digestion, reduces appetite, and helps regulate blood sugar. This is the same pathway semaglutide targets.
- GIP (glucose-dependent insulinotropic polypeptide) improves insulin sensitivity and works with GLP-1 to increase the appetite-suppressing effect. Tirzepatide already uses this combination.
- Glucagon receptor activation is what makes retatrutide different. Glucagon increases energy expenditure. It tells your liver to burn more fat. It raises your metabolic rate even at rest.
In my experience looking at the mechanistic research, the glucagon component is the real differentiator here. It is not just about eating less. Your body is also burning more. That combination is why the weight loss numbers are so much higher than what we see with GLP-1 drugs alone.
A 2023 phase 2 trial published in The New England Journal of Medicine confirmed this. Participants on the highest dose of retatrutide lost an average of 17.5% of body weight at 24 weeks and up to 24.2% at 48 weeks. The placebo group lost about 2.1%.
Does Retatrutide Really Work for Weight Loss?
Yes. The clinical data is clear on this. What I found interesting when reviewing the trial data is that the weight loss did not plateau the way it does with semaglutide. People kept losing weight through the full 48 weeks of the trial. That suggests the body does not adapt and stop responding the same way.
To put the numbers in context: semaglutide (Wegovy) produces around 15% body weight loss over 68 weeks. Tirzepatide (Mounjaro) produces around 20-22% over 72 weeks. Retatrutide hit 24% in 48 weeks. That is a faster rate of loss and a higher total reduction.
What that means practically is that someone weighing 100kg could expect to lose around 24kg over roughly a year. That is significant. That is the kind of result that changes metabolic health markers, reduces joint load, and lowers cardiovascular risk.
The research also showed improvements in fasting glucose, insulin resistance, triglycerides, and blood pressure. Weight loss was not the only outcome. The metabolic improvements tracked alongside it.
Is Retatrutide More Effective Than Semaglutide or Tirzepatide?
Based on current data, yes. Retatrutide outperforms both in head-to-head comparisons of weight loss percentage. But there are a few things worth being honest about here.
First, we do not yet have phase 3 trial data. The 24% figure comes from a phase 2 trial, which is smaller and shorter than the large-scale trials that semaglutide and tirzepatide have completed. Phase 3 results could look different.
Second, the comparison is not perfectly clean. Different trials use different populations, different durations, and different endpoints. What we can say with confidence is that the early signals for retatrutide are stronger than what semaglutide and tirzepatide showed at the same stage of development.
Third, effectiveness is not just about how much weight you lose. It is also about tolerability, side effect profile, and whether you can stay on the drug long enough to see results. A drug that produces 24% weight loss but causes severe nausea that forces you to stop is not more effective in practice.
When I looked at the side effect data across all three drugs, retatrutide had a similar profile to tirzepatide. Nausea and vomiting were the most common complaints, and they were dose-dependent. Higher doses produced more side effects.
What Are the Side Effects of Retatrutide?
The most common side effects reported in the phase 2 trial were gastrointestinal. Nausea, vomiting, diarrhea, and constipation. These are the same side effects seen with semaglutide and tirzepatide, and they tend to be worst in the first few weeks as the dose increases.
Here is the breakdown from the trial data:
- Nausea affected around 40-60% of participants at higher doses
- Vomiting affected around 20-30%
- Diarrhea and constipation were reported at similar rates
- Most side effects were mild to moderate and decreased over time
- Serious adverse events were low and comparable to placebo
What I saw in the data was that the side effect rate was higher at the 12mg dose compared to the 4mg and 8mg doses. The 8mg dose had a better tolerability profile while still producing strong weight loss results. That dose-response relationship matters when thinking about real-world use.
One thing worth flagging: glucagon receptor activation can raise heart rate. The trial noted small increases in resting heart rate in some participants. This is something to monitor, especially in people with existing cardiovascular conditions.
There is also the question of muscle loss. Rapid weight loss from any intervention can include lean mass loss alongside fat loss. The trial did not report detailed body composition data, which is a gap. This is where combining a drug like retatrutide with resistance training and adequate protein intake becomes important. The drug handles the calorie side. You still need to protect your muscle.
Is Retatrutide FDA Approved?
No. As of 2025, retatrutide is not FDA approved. It is still in clinical trials. Phase 3 trials are underway, and if those results hold up, an FDA submission could follow. But approval is likely still a few years away.
That means retatrutide is not legally available as a prescription medication in the United States, Australia, or most other countries right now. Some compounding pharmacies have started offering it, but this is in a legal grey area and the quality and dosing of compounded versions is not regulated the same way approved drugs are.
If you are considering retatrutide, the honest answer is to wait for phase 3 data and regulatory approval, or to speak with a doctor who specialises in metabolic health and can advise you on the current landscape.
Who Is a Good Candidate for Retatrutide?
Based on the trial inclusion criteria and the mechanism of action, retatrutide is likely to be most appropriate for adults who are obese (BMI over 30) or overweight (BMI 27-30) with at least one weight-related health condition like type 2 diabetes, high blood pressure, or elevated cholesterol.
People who have not responded well to semaglutide or tirzepatide may also be candidates, since the triple mechanism offers a different physiological approach.
Who is probably not a good candidate right now:
- People with a personal or family history of medullary thyroid carcinoma (same contraindication as other GLP-1 drugs)
- People with a history of pancreatitis
- Pregnant or breastfeeding women
- People with significant cardiovascular disease, given the heart rate effects
- Anyone looking for a short-term fix without lifestyle changes
That last point matters. In my experience reviewing the long-term data on GLP-1 class drugs, weight regain after stopping is significant. Studies on semaglutide show people regain about two thirds of lost weight within a year of stopping. Retatrutide will likely follow the same pattern. The drug works while you are on it. What you build around it, your eating habits, your training, your sleep, determines what happens when you come off it.
Does Retatrutide Really Work Without Exercise?
The trial participants were not required to follow a structured exercise program. So technically, yes, the weight loss happened without mandatory exercise. But that is not the full picture.
When I looked at what the glucagon component does, it increases energy expenditure. Exercise also increases energy expenditure. These two things stack. People who combine retatrutide with regular resistance training and cardiovascular exercise will almost certainly see better body composition outcomes than people who rely on the drug alone.
More importantly, exercise protects muscle mass during rapid weight loss. If you are losing 20-24% of your body weight, some of that will be muscle unless you are actively training and eating enough protein. Losing muscle slows your metabolism and makes weight regain more likely after you stop the drug.
The drug does retatrutide really work question is easy to answer with a yes. The harder question is whether the results last, and that depends heavily on what you do alongside it.
FAQ
How long does retatrutide take to work?
In the phase 2 trial, meaningful weight loss was visible by week 4-8. The biggest losses happened between weeks 12 and 24. Weight loss continued through week 48 without a clear plateau.
Is retatrutide available now?
Not as an approved medication. Phase 3 trials are ongoing. Some compounding pharmacies offer it, but this is unregulated and carries quality and safety risks.
How does retatrutide compare to Ozempic?
Retatrutide targets three receptors (GLP-1, GIP, glucagon). Ozempic targets only GLP-1. The additional mechanisms produce significantly greater weight loss in trials. Retatrutide produced roughly 24% body weight loss versus around 15% for semaglutide.
Can you use retatrutide for type 2 diabetes?
The trial showed strong improvements in blood sugar control and insulin sensitivity. It is likely to be developed for both obesity and type 2 diabetes, similar to how tirzepatide received approval for both conditions.
What happens when you stop taking retatrutide?
Based on data from similar drugs, weight regain is expected after stopping. Building sustainable habits around nutrition and training while on the drug is the best way to maintain results after discontinuation.
The Bottom Line
Retatrutide works. The phase 2 data is strong, the mechanism makes sense, and the weight loss numbers are the best we have seen from any drug in this class. The triple receptor approach is a real physiological advance, not just a marketing claim.
But it is not approved yet. It is not available as a regulated medication. And like every drug in this class, it works best as part of a broader approach that includes training, nutrition, and sleep.
If you are serious about body composition and want to understand how to build the habits that make any intervention stick, working with a qualified online personal trainer can help you build the structure around whatever medical approach you take. The drug handles one part of the equation. The rest is still on you.
